Single award · contract
Clinical Development Phase 2 Study
Award ID: W911SR22F0014
FY2022 · complete year · data as of 2026-07-11
A single federal award, with both ends of the trail linked.
$93M
Total award value
Award W911SR22F0014 is a contract from the Department of Defense, $93M obligated, FY2022 to FY2026, for Clinical Development Phase 2 Study. The work is performed in Maryland. It is classified as NAICS 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)) and PSC AN42 (Health R&D Services; Health Care - Other; Applied Research). Source
Award details
Award typeContract
PIIDW911SR22F0014
Action date2022
Period47 mo
Awarding agencyDepartment of Defense →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performanceMaryland →
CategoryNAICS 541715PSC AN42
Competed?Not recordedSource
Total (exact)$93,029,233
More from Department of Defense
awarded 2016$51.3B
awarded 2017$35.7B
awarded 2017$35.1B
awarded 2001$34.2B
awarded 2011$32B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.